A COMPARISON OF DOPAMINE RECEPTOR BLOCKING ASSAY WITH PLASMA DRUG LEVELS OF HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS

被引：16
|
作者：
KURLAND, AA [1 ]
NAGARAJU, A [1 ]
HANLON, TE [1 ]
WILKINSON, EH [1 ]
NG, KT [1 ]
机构：
[1] MCNEIL LABS INC,FT WASHINGTON,PA 19034
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 21卷 / 01期
关键词：
D O I：
10.1002/j.1552-4604.1981.tb01731.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：42 / 47
页数：6
相关论文
共 50 条
  • [1] HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS
    JANN, MW
    ERESHEFSKY, L
    SAKLAD, SR
    RICHARDS, A
    DAVIS, CM
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (06): : 507 - 507
  • [2] DRUG HOLIDAYS AND SERUM HALOPERIDOL LEVELS IN SCHIZOPHRENIC-PATIENTS
    MCMILLAN, DE
    FODY, EP
    COUCH, L
    HARRISON, RH
    NEWTON, JEO
    REESE, WG
    JOURNAL OF CLINICAL PSYCHIATRY, 1986, 47 (07) : 373 - 374
  • [3] HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-LEVELS IN SELECTED SCHIZOPHRENIC-PATIENTS
    ERESHEFSKY, L
    DAVIS, CM
    HARRINGTON, CA
    JANN, MW
    BROWNING, JL
    SAKLAD, SR
    BURCH, NR
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1984, 4 (03) : 138 - 142
  • [4] BLOOD-LEVELS OF HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
    SHVARTSBURD, A
    DEKIRMENJIAN, H
    SMITH, RC
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1983, 3 (01) : 7 - 12
  • [5] THE CONTROLLED COMPARISON OF OXYPROTHEPINE AND HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS
    NAHUNEK, K
    SVESTKA, J
    CESKOVA, E
    RYSANEK, R
    ACTIVITAS NERVOSA SUPERIOR, 1981, 23 (03): : 233 - 234
  • [6] EFFECTS OF HALOPERIDOL ON CSF GLUTAMATE LEVELS IN DRUG-NAIVE SCHIZOPHRENIC-PATIENTS
    LABARCA, R
    SILVA, H
    JEREZ, S
    RUIZ, A
    RENTERIAS, P
    OGALDE, C
    BUSTOS, G
    SCHIZOPHRENIA RESEARCH, 1995, 16 (01) : 83 - 85
  • [7] THE RELATIONSHIP OF DOPAMINE RECEPTOR BLOCKADE TO CLINICAL-RESPONSE IN SCHIZOPHRENIC-PATIENTS TREATED WITH PIMOZIDE OR HALOPERIDOL
    SILVERSTONE, T
    COOKSON, J
    BALL, R
    CHIN, CN
    JACOBS, D
    LADER, S
    GOULD, S
    JOURNAL OF PSYCHIATRIC RESEARCH, 1984, 18 (03) : 255 - 268
  • [8] PLASMA PHENYLETHYLAMINE LEVELS OF SCHIZOPHRENIC-PATIENTS
    SHIRKANDE, S
    OREILLY, R
    DAVIS, B
    DURDEN, D
    MALCOM, D
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1995, 40 (04): : 221 - 221
  • [9] PLASMA REDUCED HALOPERIDOL/HALOPERIDOL RATIOS IN SCHIZOPHRENIC-PATIENTS TREATED WITH HIGH DOSAGES OF HALOPERIDOL
    CHANG, WH
    SHIEH, YS
    LIU, HC
    JANN, MW
    CHIEN, CP
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1994, 4 (02) : 119 - 126
  • [10] PHARMACOKINETICS OF HALOPERIDOL AND HALOPERIDOL DECANOATE IN SCHIZOPHRENIC-PATIENTS
    NAYAK, RK
    NAIR, NPV
    DOOSE, DR
    MCCARTHY, LR
    DESIRAJU, RK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 217 - 217
12345